Europe Medical Cannabis Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
USD
3.51 Billion
USD
35.59 Billion
2024
2032
 예측 기간 |
2025 –2032 |
 시장 규모(기준 연도) |
USD 3.51 Billion |
 시장 규모(예측 연도) |
USD 35.59 Billion |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
유럽 의료용 대마초 시장 세분화, 제품별(오일, 건조 의료용 대마초, 의료용 대마초 캡슐, 전체 꽃, 분쇄 꽃, 베이프 펜, 크림 및 보습제 및 기타), 출처(합성 및 천연), 종(인디카 대마초, 사티바 대마초 및 하이브리드 대마초), 파생물(칸나비디올(CBD), 테트라히드로칸나비놀(THC)/델타-8-테트라히드로칸나비놀 및 기타), 응용 분야(통증 관리, 불안, 근육 경련, 메스꺼움, 식욕 부진, 암, 관절염, 알츠하이머병/편두통, 간질, 우울증 및 수면 장애, 다발성 경화증, 자폐증, 정신 건강 상태, 기분 향상 및 기타), 투여 경로(경구 용액 및 캡슐, 흡연, 증발기, 국소 및 기타), 최종 사용자(제약 산업, 연구 및 개발 센터, 홈 케어 시설, 병원, 재활 센터 및 기타), 유통 채널(B2B 및 B2C) - 2032년까지의 산업 동향 및 예측
유럽 의료용 대마 시장 규모
- 유럽 의료용 대마 시장 규모는 2024년에 35억 1천만 달러 로 평가되었으며 , 예측 기간 동안 33.60%의 CAGR 로 2032년까지 355억 9천만 달러 에 도달할 것으로 예상됩니다 .
- 시장 성장은 주로 연결된 홈 기기와 스마트 홈 기술 내에서의 채택 증가와 기술 발전에 의해 촉진되며, 이는 주거 및 상업 환경 모두에서 디지털화가 더욱 증가함을 의미합니다.
- 더욱이, 가정과 사업장을 위한 안전하고 사용자 친화적이며 통합된 솔루션에 대한 소비자 수요가 증가함에 따라 스마트 잠금장치가 현대적인 출입 통제 시스템으로 자리매김하고 있습니다. 이러한 요소들이 융합되면서 유럽 의료용 대마 솔루션의 도입이 가속화되고 있으며, 이는 업계 성장을 크게 촉진하고 있습니다.
유럽 의료용 대마초 시장 분석
- 만성 통증, 간질, 다발성 경화증, 암 관련 증상 등 다양한 질환을 치료하는 데 사용되는 제약 등급 대마초 제품을 포함하는 의료용 대마초는 규제 프레임워크의 진화와 치료적 이점에 대한 임상적 검증 증가로 인해 유럽 전역에서 점점 더 많은 수용을 경험하고 있습니다.
- 유럽의 의료용 대마초 수요는 주로 만성 질환 유병률 증가, 노인 인구 증가, 정부의 지원 정책, 카나비노이드 기반 치료법에 대한 연구 투자 증가에 의해 주도됩니다.
- 독일은 2024년 유럽 의료용 대마초 시장에서 27.9%의 가장 큰 매출 점유율을 기록하며 압도적인 우위를 점했습니다. 이는 탄탄한 보험급여 체계, 의사들의 폭넓은 도입, 그리고 강력한 환자 수요에 힘입은 것입니다. 독일의 선도적인 규제 개발과 활발한 수입 및 국내 생산 생태계는 시장 성장을 지속적으로 견인하고 있습니다.
- 이탈리아는 2024년 국내 군 시설을 통한 생산, 수입 증가, 만성 통증 및 완화 치료에 대한 지속적인 수요에 힘입어 CAGR 9.7%로 예측 기간 동안 유럽 의료용 대마 시장에서 가장 빠르게 성장하는 국가가 될 것으로 예상됩니다.
- 천연 분야는 2024년 유럽 의료용 대마초 시장에서 69.3%의 시장 점유율을 기록하며 압도적인 우위를 점했습니다. 이는 유기농 및 식물 유래 치료제에 대한 수요 증가에 기인합니다. 천연 대마초의 광범위한 사용은 천연 치료제에 대한 환자 선호도 증가와 독일, 이탈리아, 네덜란드 등 주요 유럽 국가의 우호적인 규제 정책에 힘입어 뒷받침됩니다.
보고서 범위 및 유럽 의료용 대마초 시장 세분화
|
속성 |
유럽 의료용 대마초 주요 시장 통찰력 |
|
다루는 세그먼트 |
|
|
포함 국가 |
유럽
|
|
주요 시장 참여자 |
|
|
시장 기회 |
|
|
부가가치 데이터 정보 세트 |
Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 적용 범위, 주요 기업 등 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 가격 분석, 브랜드 점유율 분석, 소비자 설문 조사, 인구 통계 분석, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함되어 있습니다. |
유럽 의료용 대마초 시장 동향
“ 의료용 대마초 치료의 개인화 및 디지털화 확대 ”
- 유럽 의료용 대마초 시장에서 중요하고 빠르게 성장하는 추세는 디지털 건강 플랫폼과 환자 모니터링 기술을 통해 개인 맞춤형 치료 접근법을 통합하는 것입니다. 이러한 진화하는 모델은 환자 참여, 투여량 정확도, 그리고 의사의 감독을 강화하여 더 나은 치료 결과를 제공합니다.
- 예를 들어, 여러 유럽 스타트업은 디지털 건강 플랫폼과 협력하여 AI 기반 대마초 복용량 추적 앱과 원격 진료 상담을 제공하여 접근성과 개인 맞춤형 치료를 개선하고 있습니다. 이러한 플랫폼은 환자에게 적정 일정을 안내하고, 증상을 추적하며, 실시간 피드백을 기반으로 품종을 조정합니다.
- 디지털 통합은 특히 통증, 불안, 간질과 같은 만성 질환 관리에 있어 원격 환자 모니터링을 가능하게 합니다. 임상의는 치료 진행 상황, 부작용 및 순응도를 원격으로 모니터링하여 의사 결정을 간소화하고 환자 안전을 강화할 수 있습니다.
- 기기, 앱, 환자 포털을 아우르는 이러한 원활한 디지털 참여는 연결된 치료 생태계를 구축하여 의료용 대마초가 더 이상 고립되지 않고 더 넓은 디지털 의료 여정의 일부가 되도록 합니다. 이를 통해 의사, 약국, 환자 간의 협력을 통해 더욱 효율적인 의료 서비스 제공이 가능해집니다.
- 유럽의 SOMAÍ Pharmaceuticals 및 Cellen Health와 같은 회사들은 가상 진료와 제품 이행 및 데이터 분석을 결합하여 다양한 유럽 규제 환경에서 확장 가능하고 규정을 준수하는 의료용 대마초 치료 프로그램을 제공하기 위해 원격 대마초 플랫폼을 적극적으로 개발하고 있습니다.
- 디지털 통합 환자 중심의 대마초 치료에 대한 수요가 아시아 태평양 전역에서 빠르게 증가하고 있으며, 특히 젊은층, 기술에 능숙한 인구와 만성 질환 환자 사이에서 수요가 급증하고 있습니다. 이러한 추세가 가속화됨에 따라 의료용 대마초 제공, 지원 및 효능 모니터링에 대한 기대치도 변화하고 있습니다.
유럽 의료용 대마초 시장 동향
운전사
“만성 질환 부담 증가 및 치료용 대마초 도입으로 인한 수요 증가”
- 암, 간질, 다발성 경화증, 만성 통증과 같은 만성 질환의 유병률 증가와 여러 유럽 국가에서 의료용 대마초 합법화의 가속화는 의료용 대마초 제품에 대한 수요 증가의 주요 원인입니다.
- 예를 들어, 2024년 4월, 스테노케어(STENOCARE A/S, 덴마크)는 만성 통증 및 신경과 치료 결과 개선을 목표로 하는 새로운 오일 기반 의료용 대마초 제형을 출시하여 제품군을 확장할 계획을 발표했습니다. 주요 기업들의 이러한 전략은 예측 기간 동안 유럽 의료용 대마초 산업 성장을 견인할 것으로 예상됩니다.
- 환자와 의료 서비스 제공자들이 의료용 대마초가 기존 의약품에 비해 임상적 이점과 부작용이 적다는 사실을 더욱 인식하게 되면서, 대마초 유래 치료제에 대한 수요는 계속해서 증가하고 있습니다. 이러한 제품들은 통증 관리, 완화 치료, 정신 건강 등의 분야에서 매력적인 대안을 제시합니다.
- 또한 규제 개혁, 시범 프로그램 및 수입 승인을 통한 유럽 정부의 지원이 증가함에 따라 의료용 대마초가 환자들의 접근성을 높여 주류 의료 시스템에 통합되는 속도가 빨라지고 있습니다.
- 오일, 캡슐, 스프레이 등 다양한 제형의 편의성과 전자 처방 서비스 및 약국 기반 유통 확대는 입원 및 외래 환자 진료 분야에서 의료용 대마초 도입을 촉진하는 주요 요인입니다. 식물 기반 치료법에 대한 추세와 대체 의학에 대한 수용 증가 또한 시장 성장에 크게 기여하고 있습니다.
제지/도전
“ 규제 복잡성과 높은 치료 비용에 대한 우려 ”
- 유럽 전역에서 분열되고 끊임없이 변화하는 규제 환경에 대한 우려는 더 넓은 시장 진출에 심각한 난관을 초래합니다. 국가 간 법률, 허가 체계, 그리고 수출입 제한으로 인해 제조업체와 유통업체가 지역 내에서 원활하게 사업을 운영하는 데 어려움을 겪고 있습니다.
- 예를 들어, 독일과 영국과 같은 국가는 의료용 대마초에 대한 체계가 잘 확립되어 있는 반면, 다른 국가들은 여전히 초기 단계의 정책 시행에 어려움을 겪고 있어 투자자와 의료 서비스 제공자에게 지연과 불확실성을 초래하고 있습니다.
- EU 전역의 조화로운 법률, 표준화된 제품 품질 가이드라인, 그리고 투명한 허가 절차를 통해 이러한 규제 장벽을 해소하는 것은 탄탄하고 확장 가능한 산업을 구축하는 데 필수적입니다. Aurora Cannabis와 Tilray Brands와 같은 기업들은 접근성을 확대하고 규정 준수를 간소화하기 위해 규제 기관과 적극적으로 협력하고 있습니다.
- 또한, 의료용 대마초의 비교적 높은 치료비, 특히 수입 제품이나 GMP 인증 제품의 경우, 이는 무보험이거나 비용에 민감한 환자의 의료용 대마초 도입에 걸림돌이 될 수 있습니다. 일부 국가에서는 부분적인 의료비 상환을 제공하고 있지만, 많은 지역에서는 여전히 의료용 대마초의 접근성이 제한적입니다.
- 지역 생산 증가로 인해 가격 경쟁력이 점차 높아지고 있지만, 대마초를 고급 치료법이나 실험적 치료법으로 인식하는 바람에 보수적인 의료계에서는 대마초를 광범위하게 도입하는 데 어려움을 겪고 있습니다.
- 규제 조정, 의사 교육, 대중 교육 및 보다 저렴하고 증거가 뒷받침되는 의료용 대마초 제품 개발을 통해 이러한 과제를 극복하는 것은 유럽 의료용 대마초 시장의 지속적인 성장을 위해 필수적입니다.
유럽 의료용 대마초 시장 범위
시장은 제품, 출처, 종, 파생물, 응용 분야, 투여 경로, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다.
• 제품별
유럽 의료용 대마초 시장은 제품 기준으로 오일, 건조 의료용 대마초, 의료용 대마초 캡슐, 꽃 전체, 가루 꽃, 베이프 펜, 크림 및 보습제 등으로 구분됩니다. 오일 부문은 정확한 용량, 투여 용이성, 만성 질환 치료에 대한 선호도 덕분에 2024년 시장 매출 점유율 34.6%를 기록하며 가장 큰 비중을 차지했습니다.
의료용 대마초 캡슐 부문은 2025년부터 2032년까지 연평균 성장률 22.9%로 가장 빠른 성장률을 보일 것으로 예상됩니다. 이는 환자 순응도 향상과 신경 및 통증 관련 질환에 대한 처방 확대에 따른 것입니다.
• 출처별
유럽 의료용 대마초 시장은 출처를 기준으로 합성 대마초와 천연 대마초로 구분됩니다. 천연 대마초 부문은 유기농 및 식물 유래 치료제 수요 증가에 힘입어 2024년 전체 매출의 69.3%를 차지하며 가장 큰 비중을 차지했습니다.
합성 부문은 실험실에서 제조된 칸나비노이드 제형의 발전으로 인해 2025년부터 2032년까지 20.4%의 가장 빠른 CAGR을 기록할 것으로 예상됩니다.
• 종별
유럽 의료용 대마초 시장은 종을 기준으로 인디카 대마초, 사티바 대마초, 그리고 하이브리드 대마초로 구분됩니다. 인디카 대마초는 2024년 시장 점유율 41.7%로 가장 큰 비중을 차지했으며, 통증과 불면증 완화에 진정 효과가 있어 널리 사용됩니다.
하이브리드 부문은 2025년부터 2032년까지 21.3%의 가장 빠른 CAGR을 기록할 것으로 예상되며, 균형 잡힌 치료 효과로 인해 선호됩니다.
• 파생상품으로
유럽 의료용 대마초 시장은 파생상품을 기준으로 칸나비디올(CBD), 테트라히드로칸나비놀(THC)/델타-8-테트라히드로칸나비놀, 그리고 기타로 구분됩니다. 칸나비디올(CBD) 부문은 향정신성 물질이 없고 치료 잠재력이 뛰어나 2024년 전체 매출의 57.8%를 차지하며 가장 큰 비중을 차지했습니다.
테트라히드로카나비놀(THC) 부문은 종양학 및 완화 치료 분야에서 통증과 메스꺼움 관리에 대한 합법화와 수용이 증가함에 따라 2025년부터 2032년까지 23.1%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 응용 프로그램별
유럽 의료용 대마초 시장은 적용 분야별로 통증 관리, 불안, 근육 경련, 메스꺼움, 식욕 부진, 암, 관절염, 알츠하이머병/편두통, 간질, 우울증 및 수면 장애, 다발성 경화증, 자폐증, 정신 질환, 기분 상승 등으로 세분화됩니다. 통증 관리 분야는 2024년 매출 점유율 38.5%로 1위를 차지했으며, 암 관련 분야가 14.2%로 그 뒤를 이었습니다.
간질 분야는 발작 조절에 대한 카나비노이드 효능을 뒷받침하는 임상적 증거가 증가함에 따라 2025년부터 2032년까지 22.6%의 가장 빠른 CAGR을 기록할 것으로 예상됩니다.
• 투여 경로별
유럽 의료용 대마초 시장은 투여 경로를 기준으로 경구용 용액 및 캡슐, 흡연용, 기화기, 국소용 등으로 구분됩니다. 경구용 용액 및 캡슐 부문은 사용 편의성과 정확한 용량 투여로 2024년 시장 점유율 36.8%로 가장 큰 비중을 차지했습니다.
증기기 부문은 2025년부터 2032년까지 21.5%의 가장 빠른 CAGR을 기록할 것으로 예상되며, 빠른 작용 발현과 젊은 세대에서 점점 더 많이 사용되고 있어 선호됩니다.
• 최종 사용자별
유럽 의료용 대마초 시장은 최종 사용자 기준으로 제약 산업, 연구개발 센터, 재택 치료 시설, 병원, 재활 센터 등으로 세분화됩니다. 제약 산업 부문은 임상 시험 및 신약 개발 증가에 힘입어 2024년 32.4%의 매출 점유율을 기록하며 가장 큰 비중을 차지했습니다.
홈 케어 환경 부문은 환자 중심적이고 가정 기반 대마초 치료에 대한 수요 증가에 힘입어 2025년부터 2032년까지 22.7%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 유통 채널별
유통 채널을 기준으로 시장은 B2B와 B2C로 구분됩니다. B2B 부문은 2024년 기준 60.1%의 매출 점유율을 기록하며 가장 큰 매출 점유율을 차지했으며, 이는 약국과 병원의 대량 구매에 기인합니다.
B2C 부문은 유럽 전역의 전자 약국과 직접 소비자 플랫폼의 증가로 인해 2025년부터 2032년까지 24.2%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
유럽 의료용 대마초 시장 지역 분석
- 독일은 2024년 유럽 의료용 대마초 시장에서 27.9%의 가장 큰 매출 점유율을 기록하며 압도적인 우위를 점했습니다. 이는 확립된 규제 체계, 광범위한 의사 도입, 그리고 보험 적용 처방에 힘입은 것입니다. 독일의 강력한 수입 역량과 국내 생산 확대는 환자 접근성을 더욱 높이고 장기적인 시장 주도권을 유지하고 있습니다.
- 주요 유럽 국가의 소비자들은 만성 통증, 신경 질환, 암 관련 증상 및 정신 건강 지원을 위해 의료용 대마초를 점점 더 많이 사용하고 있으며, 안전성, 효능 및 처방 기반 접근성을 갖춘 오일, 말린 꽃 및 캡슐과 같은 규제 제품을 선호하고 있습니다.
- 대마초 유래 치료법에 대한 인식 증가, 만성 질환 유병률 증가, 그리고 대마초 관련 법규의 점진적인 개혁은 유럽 대륙 전역의 수요를 가속화하고 있습니다. 영국, 프랑스, 이탈리아와 같은 국가에서는 대마초 접근 프로그램 및 임상시험에 대한 환자 등록이 증가하고 있습니다.
영국 유럽 의료용 대마초 시장 통찰력
영국-유럽 의료용 대마초 시장은 2024년 유럽 의료용 대마초 시장에서 18.6%의 매출 점유율을 기록했습니다. 이는 민간 대마초 클리닉 수 증가, 대마초에 대한 인식 제고, 그리고 국민보건서비스(NHS) 외에서 치료를 받으려는 환자들의 의지에 힘입은 것입니다. 디지털 처방 플랫폼 확대와 규제의 명확성 개선으로 강력한 성장이 예상됩니다.
프랑스 유럽 의료용 대마초 시장 통찰력
프랑스 유럽 의료용 대마초 시장은 2024년 유럽 의료용 대마초 시장의 11.3%를 차지했으며, 이는 국가 의료용 대마초 시범 프로그램과 정부 지원 확대에 힘입은 것입니다. 시범 시행 후 본격적인 시장 진입은 예측 기간 동안 성장을 크게 촉진할 것으로 예상됩니다.
이탈리아 유럽 의료용 대마초 시장 통찰력
이탈리아 유럽 의료용 대마초 시장은 2024년에 9.7%의 연평균 성장률을 기록하며 가장 높은 성장률을 기록할 것으로 예상됩니다. 이는 군 시설을 통한 국내 생산, 수입 증가, 그리고 만성 통증 및 완화 치료에 대한 꾸준한 수요에 힘입은 것입니다. 이탈리아의 성숙한 규제 구조는 시장 안정성을 지속적으로 뒷받침합니다.
유럽 의료용 대마 시장 점유율
유럽 의료용 대마 산업은 주로 다음을 포함한 잘 확립된 회사들이 주도하고 있습니다.
- Aurora Cannabis Inc. (캐나다)
- 캐노피 그로스 코퍼레이션 (캐나다)
- Tilray Brands, Inc. (캐나다)
- 재즈 파마슈티컬스 주식회사 (아일랜드)
- STENOCARE A/S (덴마크)
- Demecan GmbH (독일)
- Wayland Group Corp. (독일)
- Cannamedical Pharma GmbH (독일)
- Bedrocan International BV (네덜란드)
- 파낙시아 제약 산업 유한회사 (이스라엘)
- IM Cannabis Corp. (이스라엘)
- 리틀 그린 파마(Little Green Pharma Ltd.) (호주)
- PharmaCielo Ltd. (캐나다)
- Khiron Life Sciences Corp. (콜롬비아)
- 알테아 그룹 홀딩스 유한회사 (호주)
유럽 의료용 대마초 시장의 최신 동향
- 2024년 5월 , 독일의 대마초법이 발효되어 대마초가 마약에서 공인 의약품으로 재분류되었습니다. 이러한 규제 변화로 원격 진료, 처방 간소화, 그리고 개인 재배 및 소지 합법화가 가능해져 시장이 급속도로 성장했습니다. 독일의 환자 수는 2024년 4월 25만 명에서 2025년 5월에는 거의 90만 명으로 급증했으며, 시장 규모는 연간 10억 유로(약 11억 달러)를 돌파할 것으로 예상됩니다.
- 2025년 1월 , Aurora Cannabis는 IndiMed 브랜드로 첫 번째 독일산 의료용 대마초 출시를 발표하며 유럽 시장에서 수직적 통합과 현지 공급 전략이 확대되고 있음을 알렸습니다.
- 2024 년 6월 , Glass Pharms는 우편을 통해 MHRA 허가를 받은 현지 재배 대마초 꽃을 배달한 최초의 영국 기반 생산자가 되었으며, 이는 유럽의 국내 생산 및 유통 역량에 있어 이정표를 세웠습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of Europe MEDICAL CANNABIS market
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- PRODUCT LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- market application coverage grid
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- EUROPE MEDICAL CANNABIS MARKET: REGULATIONS
- UNITED STATES
- CANADA
- AUSTRALIA
- THAILAND
- EUROPE MEDICAL CANNABIS MARKET: SUPPLY CHAIN ANALYSIS
- CULTIVATORS AND GROWERS
- MANUFACTURER AND PRODUCER
- TESTERS
- WHOLESALE AND DISTRIBUTORS
- RETAILERS
- Market Overview
- DRIVERS
- INCREASED MEDICINAL USE
- LEGALIZATION OF CANNABIS
- INITIATIVES TAKEN BY MANUFACTURERS
- INCREASED USAGE OF CANNABIS SEEDS IN COSMETIC PRODUCTS
- FUNCTIONAL PROPERTIES OF CANNABIS AND THEIR INCREASED USE IN DIFFERENT INDUSTRIES
- RESTRAINTS
- COMPLEX REGULATORY STRUCTURE FOR USAGE OF CANNABIS
- LONG TERM USE CAN CAUSE ADVERSE EFFECTS
- HIGH COST
- OPPORTUNITIES
- NOVEL PRODUCT DEVELOPMENT WITH INCREASING R & D ACTIVITIES
- INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSE
- GROWING GERIATRIC POPULATION
- INCREASING PREVALENCE OF CHRONIC DISEASES
- CHALLENGES
- RISE OF MARIJUANA BLACK MARKET
- SIDE EFFECTS RELATED TO THE USE OF CANNABIS
- SHORTAGE OF PERSONNEL
- IMPACT OF COVID-19 ON EUROPE MEDICAL CANNABIS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY
- KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
- CONCLUSION:
- EUROPE MEDICAL CANNABIS MARKET, BY product
- overview
- oil
- By Type
- CBD Oil Concentrates
- CBD Vape Oil
- CBD Tinctures
- By Source
- Marijuana Based
- Hemp Based
- By Species
- Sativa
- Hybrid
- Cannabis Indica
- Dried Medical cannabis
- Cannabis Indica
- Sativa
- Hybrid
- medical cannabis capsules
- By Type
- Oil Based Cannabis Capsules
- Power Based Cannabis Capsules
- Others
- By Concentrates
- High CBD Capsules Digital
- High THC Capsule
- THC/CBD balanced capsule
- CBD Isolate Capsule
- By Species
- Sativa
- Hybrid
- Cannabis Indica
- vape pen
- Cannabis Indica
- Sativa
- Hybrid
- whole flower
- Sativa
- Hybrid
- Cannabis Indica
- CREAMS & MOISTURIZER
- Ground Flower
- Sativa
- Cannabis Indica
- Hybrid
- patch
- mask & serum
- cleanser
- others
- EUROPE MEDICAL CANNABIS MARKET, BY application
- overview
- pain management
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Creams & Moisturizer
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- anxiety
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- muscle spasms
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Creams & Moisturizer
- Ground Flower
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- nausea
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Ground Flower
- Creams & Moisturizer
- Patch
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- appetite loss
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Ground Flower
- Whole Flower
- Vape Pen
- Patch
- Others
- cancer
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- arthritis
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Creams & Moisturizer
- Masks & Serum
- Whole Flower
- Vape Pen
- Cleanser
- Others
- alzheimer’s disease/Migranes
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- epilepsy
- Oil
- Medical cannabis and capsules
- Others
- depression and sleep disorders
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Creams & Moisturizer
- Others
- multiple sclerosis
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- autism
- Oil
- Medical cannabis and capsules
- Others
- mental health conditions
- Oil
- Medical cannabis and capsules
- Others
- elevate Mood
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Creams & Moisturizer
- Masks & Serum
- Cleanser
- Others
- others
- EUROPE MEDICAL CANNABIS MARKET, BY derivatives
- overview
- CANNABIDIOL (CBD)
- Oil
- Medical Cannabis Capsules
- Ground Flower
- Patch
- Creams & Moisturizer
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- tetrahydrocannabinol (thc)/Delta-8-TETRAHYDROCANNABINOL
- Oil
- Medical Cannabis Capsules
- Dried Medical Cannabis
- Ground Flower
- Patch
- Creams & Moisturizer
- Whole Flower
- Vape Pen
- Masks & Serum
- Cleanser
- Others
- CANNABIGEROL (CBG)
- Oil
- Whole Flower
- Medical cannabis and capsules
- Cleanser
- cannabinol (CBN)
- others
- EUROPE MEDICAL CANNABIS MARKET, BY source
- overview
- natural
- synthetic
- EUROPE MEDICAL CANNABIS MARKET, BY species
- overview
- sativa
- hybrid
- cannabis indica
- EUROPE MEDICAL CANNABIS MARKET, BY route of administration
- overview
- oral solutions and capsules
- smoking
- topicals
- vaporizers
- others
- EUROPE MEDICAL CANNABIS MARKET, BY end user
- overview
- homecare setting
- hospital
- rehab centers
- PHARMACEUTICAL INDUSTRY
- research and development centers
- others
- EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL
- overview
- B2C
- Pharmacies
- Conventional Stores
- Online Stores
- Others
- B2B
- Europe medical cannabis MARKET by geography
- europe
- germany
- italy
- u.k.
- NETHERLANDS
- switzerland
- france
- russia
- spain
- belgium
- rest of europe
- Europe Medical Cannabis market: COMPANY landscape
- company share analysis: Europe
- Swot analysis
- company profile
- MEDIPHARM LABS INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- APHRIA INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- tilray
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zenabis Europe Ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AURORA CANNABIS
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- gw pharmaceuticals plc
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Althea Company Pty Ltd (A subsidiary of Althea Group)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Apothecanna
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- bARNEY’S FARM
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Bioactive solutions, inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- bol pharma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- CANNABIS SEEDS USA
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- canopy growth corporation
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Cresco Labs
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Crop King Seeds
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- discover health llc
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- EcoGen Biosciences
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Elixinol Europe limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- endoca
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- EXTRACTAS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- FOLIUM BIOSCIENCES
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- GREENWICH BIOSCIENCES, INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HARMONY
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HUMBOLDT SEED COMPANY
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- IDT AUSTRALIA
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- kiehl’s (a subsidiary of L'Oréal)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- mary’s nutritionals, LLC
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- medical marijuana, inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- MEDIFARM
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pacific roots
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pharmahemp
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pure ratios
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- PEACE NATURALS PROJECT INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- seed Cellar
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SEEDS FOR ME
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- THC EUROPE GROUP LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- upstate elevator supply co.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- vermont hemp health
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
표 목록
TABLE 1 Annual Cost of Cultivation:
TABLE 2 Annual Cost of Manufacturing:
TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED
TABLE 26 Europe MEDICAL CANNABIS market, By application, 2019-2028 (USD million)
TABLE 27 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 28 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 29 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by anxiety, By Region, 2021-2028 (USD Million)
TABLE 30 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 31 EUROPE muscle spasms IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 32 Europe muscle spasms in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 33 EUROPE nausea IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 34 Europe nausea in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 35 EUROPE appetite loss IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 36 Europe appetite loss in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 37 EUROPE cancer IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 38 Europe cancer in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 39 EUROPE arthritis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 40 Europe arthritis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 41 EUROPE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 42 Europe ALZHEIMER’S DISEASE/MIGRANES in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 43 EUROPE epilepsy IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 44 Europe epilepsy in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 45 EUROPE depression and sleep disorders IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 46 Europe depression and sleep disorders in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 47 EUROPE multiple sclerosis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 48 Europe multiple sclerosis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 49 EUROPE autism IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 50 Europe autism in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 51 EUROPE mental health conditions IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 52 Europe mental health conditions in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 53 EUROPE elevate mood IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 54 Europe elevate mood in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 55 EUROPE others IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 65 Europe medical cannabis Market, BY source, 2019-2028 (USD MILLION)
TABLE 66 Europe natural in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 67 Europe synthetic in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 68 Europe medical cannabis Market, By Species, 2019-2028 (USD Million)
TABLE 69 Europe sativa in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 70 Europe hybrid in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 71 Europe cannabis indica in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 72 Europe medical cannabis Market, By route of administration, 2019-2028 (USD Million)
TABLE 73 Europe oral solutions and capsules in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 74 Europe smoking in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 75 Europe topicals in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 76 Europe vaporizers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 77 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 78 Europe medical cannabis Market, BY end user, 2019-2028 (USD MILLION)
TABLE 79 Europe homecare setting in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 80 Europe hospital in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 81 Europe rehab centers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 82 Europe pharmaceutical industry in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 83 Europe research and development centers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 84 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 85 Europe medical cannabis Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)
TABLE 86 Europe b2c in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 87 Europe b2C in medical cannabis Market, By distribution channel, 2019-2028 (USD Million)
TABLE 88 Europe b2b in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 89 europe medical cannabis Market, By COUNTRY, 2021-2028 (USD million)
TABLE 90 EUROPE medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 91 EUROPE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 92 EUROPE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 93 EUROPE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 94 EUROPE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 95 EUROPE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 96 EUROPE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 97 EUROPE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 98 EUROPE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 99 EUROPE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 100 EUROPE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 101 EUROPE medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 102 EUROPE medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 103 EUROPE medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 104 EUROPE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 105 EUROPE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 106 EUROPE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 107 EUROPE medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 108 EUROPE pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 109 EUROPE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 110 EUROPE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 111 EUROPE nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 112 EUROPE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 113 EUROPE cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 114 EUROPE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 115 EUROPE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 116 EUROPE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 117 EUROPE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 118 EUROPE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 119 EUROPE autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 120 EUROPE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 121 EUROPE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 122 EUROPE medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 123 EUROPE medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 124 EUROPE medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 125 EUROPE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 126 GERMANY medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 127 GERMANY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 128 GERMANY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 129 GERMANY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 130 GERMANY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 131 GERMANY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 132 GERMANY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 133 GERMANY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 134 GERMANY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 135 GERMANY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 136 GERMANY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 137 GERMANY medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 138 GERMANY medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 139 GERMANY medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 140 GERMANY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 141 GERMANY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 142 GERMANY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 143 GERMANY medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 144 GERMANY pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 145 GERMANY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 146 GERMANY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 147 GERMANY nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 148 GERMANY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 149 GERMANY cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 150 GERMANY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 151 GERMANY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 152 GERMANY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 153 GERMANY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 154 GERMANY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 155 GERMANY autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 156 GERMANY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 157 GERMANY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 158 GERMANY medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 159 GERMANY medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 160 GERMANY medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 161 GERMANY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 162 ITALY medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 163 ITALY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 164 ITALY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 165 ITALY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 166 ITALY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 167 ITALY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 168 ITALY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 169 ITALY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 170 ITALY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 171 ITALY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 172 ITALY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 173 ITALY medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 174 ITALY medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 175 ITALY medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 176 ITALY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 177 ITALY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 178 ITALY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 179 ITALY medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 180 ITALY pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 181 ITALY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 182 ITALY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 183 ITALY nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 184 ITALY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 185 ITALY cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 186 ITALY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 187 ITALY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 188 ITALY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 189 ITALY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 190 ITALY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 191 ITALY autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 192 ITALY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 193 ITALY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 194 ITALY medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 195 ITALY medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 196 ITALY medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 197 ITALY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 198 U.K. medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 199 U.K. type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 200 U.K. source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 201 U.K. species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 202 U.K. dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 203 U.K. type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 204 U.K. concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 205 U.K. species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 206 U.K. vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 207 U.K. whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 208 U.K. ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 209 U.K. medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 210 U.K. medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 211 U.K. medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 212 U.K. cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 213 U.K. tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 214 U.K. cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 215 U.K. medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 216 U.K. pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 217 U.K. anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 218 U.K. muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 219 U.K. nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 220 U.K. appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 221 U.K. cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 222 U.K. arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 223 U.K. alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 224 U.K. epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 225 U.K. depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 226 U.K. multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 227 U.K. autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 228 U.K. mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 229 U.K. elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 230 U.K. medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 231 U.K. medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 232 U.K. medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 233 U.K. B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 234 NETHERLANDS medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 235 NETHERLANDS type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 236 NETHERLANDS source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 237 NETHERLANDS species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 238 NETHERLANDS dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 239 NETHERLANDS type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 240 NETHERLANDS concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 241 NETHERLANDS species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 242 NETHERLANDS vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 243 NETHERLANDS whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 244 NETHERLANDS ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 245 NETHERLANDS medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 246 NETHERLANDS medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 247 NETHERLANDS medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 248 NETHERLANDS cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 249 NETHERLANDS tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 250 NETHERLANDS cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 251 NETHERLANDS medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 252 NETHERLANDS pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 253 NETHERLANDS anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 254 NETHERLANDS muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 255 NETHERLANDS nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 256 NETHERLANDS appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 257 NETHERLANDS cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 258 NETHERLANDS arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 259 NETHERLANDS alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 260 NETHERLANDS epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 261 NETHERLANDS depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 262 NETHERLANDS multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 263 NETHERLANDS autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 264 NETHERLANDS mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 265 NETHERLANDS elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 266 NETHERLANDS medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 267 NETHERLANDS medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 268 NETHERLANDS medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 269 NETHERLANDS B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 270 SWITZERLAND medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 271 SWITZERLAND type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 272 SWITZERLAND source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 273 SWITZERLAND species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 274 SWITZERLAND dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 275 SWITZERLAND type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 276 SWITZERLAND concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 277 SWITZERLAND species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 278 SWITZERLAND vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 279 SWITZERLAND whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 280 SWITZERLAND ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 281 SWITZERLAND medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 282 SWITZERLAND medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 283 SWITZERLAND medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 284 SWITZERLAND cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 285 SWITZERLAND tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 286 SWITZERLAND cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 287 SWITZERLAND medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 288 SWITZERLAND pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 289 SWITZERLAND anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 290 SWITZERLAND muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 291 SWITZERLAND nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 292 SWITZERLAND appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 293 SWITZERLAND cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 294 SWITZERLAND arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 295 SWITZERLAND alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 296 SWITZERLAND epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 297 SWITZERLAND depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 298 SWITZERLAND multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 299 SWITZERLAND autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 300 SWITZERLAND mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 301 SWITZERLAND elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 302 SWITZERLAND medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 303 SWITZERLAND medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 304 SWITZERLAND medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 305 SWITZERLAND B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 306 FRANCE medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 307 FRANCE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 308 FRANCE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 309 FRANCE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 310 FRANCE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 311 FRANCE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 312 FRANCE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 313 FRANCE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 314 FRANCE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 315 FRANCE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 316 FRANCE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 317 FRANCE medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 318 FRANCE medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 319 FRANCE medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 320 FRANCE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 321 FRANCE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 322 FRANCE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 323 FRANCE medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 324 FRANCE pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 325 FRANCE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 326 FRANCE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 327 FRANCE nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 328 FRANCE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 329 FRANCE cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 330 FRANCE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 331 FRANCE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 332 FRANCE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 333 FRANCE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 334 FRANCE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 335 FRANCE autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 336 FRANCE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 337 FRANCE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 338 FRANCE medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 339 FRANCE medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 340 FRANCE medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 341 FRANCE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 342 RUSSIA medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 343 RUSSIA type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 344 RUSSIA source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 345 RUSSIA species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 346 RUSSIA dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 347 RUSSIA type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 348 RUSSIA concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 349 RUSSIA species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 350 RUSSIA vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 351 RUSSIA whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 352 RUSSIA ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 353 RUSSIA medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 354 RUSSIA medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 355 RUSSIA medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 356 RUSSIA cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 357 RUSSIA tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 358 RUSSIA cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 359 RUSSIA medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 360 RUSSIA pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 361 RUSSIA anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 362 RUSSIA muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 363 RUSSIA nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 364 RUSSIA appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 365 RUSSIA cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 366 RUSSIA arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 367 RUSSIA alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 368 RUSSIA epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 369 RUSSIA depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 370 RUSSIA multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 371 RUSSIA autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 372 RUSSIA mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 373 RUSSIA elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 374 RUSSIA medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 375 RUSSIA medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 376 RUSSIA medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 377 RUSSIA B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 378 SPAIN medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 379 SPAIN type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 380 SPAIN source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 381 SPAIN species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 382 SPAIN dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 383 SPAIN type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 384 SPAIN concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 385 SPAIN species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 386 SPAIN vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 387 SPAIN whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 388 SPAIN ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 389 SPAIN medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 390 SPAIN medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 391 SPAIN medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 392 SPAIN cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 393 SPAIN tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 394 SPAIN cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 395 SPAIN medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 396 SPAIN pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 397 SPAIN anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 398 SPAIN muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 399 SPAIN nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 400 SPAIN appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 401 SPAIN cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 402 SPAIN arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 403 SPAIN alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 404 SPAIN epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 405 SPAIN depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 406 SPAIN multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 407 SPAIN autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 408 SPAIN mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 409 SPAIN elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 410 SPAIN medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 411 SPAIN medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 412 SPAIN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 413 SPAIN B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 414 BELGIUM medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 415 BELGIUM type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 416 BELGIUM source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 417 BELGIUM species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 418 BELGIUM dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 419 BELGIUM type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 420 BELGIUM concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 421 BELGIUM species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 422 BELGIUM vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 423 BELGIUM whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 424 BELGIUM ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 425 BELGIUM medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 426 BELGIUM medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 427 BELGIUM medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 428 BELGIUM cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 429 BELGIUM tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 430 BELGIUM cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 431 BELGIUM medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 432 BELGIUM pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 433 BELGIUM anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 434 BELGIUM muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 435 BELGIUM nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 436 BELGIUM appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 437 BELGIUM cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 438 BELGIUM arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 439 BELGIUM alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 440 BELGIUM epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 441 BELGIUM depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 442 BELGIUM multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 443 BELGIUM autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 444 BELGIUM mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 445 BELGIUM elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 446 BELGIUM medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 447 BELGIUM medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 448 BELGIUM medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 449 BELGIUM B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 450 rest of europe medical cannabis Market, By product, 2021-2028 (USD million)
그림 목록
FIGURE 1 Europe medical cannabis market: segmentation
FIGURE 2 Europe medical cannabis market: data triangulation
FIGURE 3 Europe medical cannabis market: DROC ANALYSIS
FIGURE 4 Europe medical cannabis market : Europe vs REGIONAL MARKET ANALYSIS
FIGURE 5 Europe medical cannabis market : COMPANY RESEARCH ANALYSIS
FIGURE 6 Europe medical cannabis market: INTERVIEW DEMOGRAPHICS
FIGURE 7 Europe medical cannabis market: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE medical cannabis MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 Europe medical cannabis market: vendor share analysis
FIGURE 10 Europe medical cannabis market: SEGMENTATION
FIGURE 11 increasing medicinal use and legalization of medical cannabis are expected to drive THE Europe medical cannabis market IN THE FORECAST PERIOD of 2021 to 2028
FIGURE 12 oil segment is expected to account for the largest share of the Europe medical cananbis market in 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MEDICAL CANNABIS MARKET
FIGURE 14 Europe MEDICAL CANNABIS market: BY product, 2020
FIGURE 15 Europe MEDICAL CANNABIS market: BY product, 2021-2028 (USD Million)
FIGURE 16 Europe MEDICAL CANNABIS market: BY product, CAGR (2021-2028)
FIGURE 17 Europe MEDICAL CANNABIS market: BY product, LIFELINE CURVE
FIGURE 18 Europe MEDICAL CANNABIS market: BY application, 2020
FIGURE 19 Europe MEDICAL CANNABIS market: BY application, 2021-2028 (USD Million)
FIGURE 20 Europe MEDICAL CANNABIS market: BY application, CAGR (2021-2028)
FIGURE 21 Europe MEDICAL CANNABIS market: BY application, LIFELINE CURVE
FIGURE 22 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2020
FIGURE 23 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2021-2028 (USD Million)
FIGURE 24 Europe MEDICAL CANNABIS market: BY DERIVATIVES, CAGR (2021-2028)
FIGURE 25 Europe MEDICAL CANNABIS market: BY DERIVATIVES, LIFELINE CURVE
FIGURE 26 Europe MEDICAL CANNABIS market: BY source, 2020
FIGURE 27 Europe MEDICAL CANNABIS market: BY source, 2021-2028 (USD Million)
FIGURE 28 Europe MEDICAL CANNABIS market: BY source, CAGR (2021-2028)
FIGURE 29 Europe MEDICAL CANNABIS market: BY source, LIFELINE CURVE
FIGURE 30 Europe MEDICAL CANNABIS market: BY species, 2020
FIGURE 31 Europe MEDICAL CANNABIS market: BY species, 2021-2028 (USD Million)
FIGURE 32 Europe MEDICAL CANNABIS market: BY species, CAGR (2021-2028)
FIGURE 33 Europe MEDICAL CANNABIS market: BY species, LIFELINE CURVE
FIGURE 34 Europe MEDICAL CANNABIS market: BY route of administration, 2020
FIGURE 35 Europe MEDICAL CANNABIS market: BY route of administration, 2021-2028 (USD Million)
FIGURE 36 Europe MEDICAL CANNABIS market: BY route of administration, CAGR (2021-2028)
FIGURE 37 Europe MEDICAL CANNABIS market: BY route of administration, LIFELINE CURVE
FIGURE 38 Europe MEDICAL CANNABIS market: BY end user, 2020
FIGURE 39 Europe MEDICAL CANNABIS market: BY end user, 2021-2028 (USD Million)
FIGURE 40 Europe MEDICAL CANNABIS market: BY end user, CAGR (2021-2028)
FIGURE 41 Europe MEDICAL CANNABIS market: BY end user, LIFELINE CURVE
FIGURE 42 Europe MEDICAL CANNABIS market: BY distribution channel, 2020
FIGURE 43 Europe MEDICAL CANNABIS market: BY distribution channel , 2021-2028 (USD Million)
FIGURE 44 Europe MEDICAL CANNABIS market: BY distribution channel , CAGR (2021-2028)
FIGURE 45 Europe MEDICAL CANNABIS market: BY distribution channel, LIFELINE CURVE
FIGURE 46 europe medical cannabis MARKET: SNAPSHOT (2020)
FIGURE 47 europe medical cannabis MARKET: BY COUNTRY (2020)
FIGURE 48 europe medical cannabis MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 europe medical cannabis MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 europe medical cannabis MARKET: BY type (2021-2028)
FIGURE 51 Europe Medical Cannabis market: company share 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
